Dextrose Monohydrate 5% Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dextrose Monohydrate 5% Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Feb 14, 2022. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 65219-458-30
- Dosage Form
- Injection
- Presentation
- Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-458-30)
- Initial Posting
- Feb 14, 2022
Reason
Demand increase for the drug